He's calling roll. Mad Money host Jim Cramer has new graduation guidelines to make school a better investment.» Read More
In an exclusive interview, Bill Clinton told CNBC's Maria Bartiromo that the IMF should not come to Europe's aide just yet. CNBC's Steve Liesman & Rick Santelli weigh in.
Jonathan Golub, UBS chief U.S. equity strategist, explains what the market activity reveals about the crisis in Europe now. Bruce Kasman, JPMorgan chief economist and CNBC's Steve Liesman, also weigh in.
Arthur Cashin, UBS director of floor operations, provides his perspective on Tuesday's market moving activity.
The China market may be due for more downside after the benchmark Shanghai Composite suffered its worst fall so far in 2012, losing 2.73 percent to 2308.55 on Monday.
"People are buying based on what their friends are buying, and Facebook has an incredible opportunity there," says Shervin Pishevar, Menlo Ventures managing director, explaining why he believes in Facebook over the long-term, and discussing growing competition among social networking markets.
The "Squawk Box" news team weighs in with their perspective on the markets ahead of the opening bell, including a look at billionaire hedge fund manager, John Paulson spending some of his fortune on a palace in the mountains, with CNBC'S Robert Frank.
We are at the start of a "silver market lining," says Jeff Weiss, Tejas Securities Group, charting the market's direction and explaining why he is detecting support levels at the 1240 to 1260 region for the S&P 500.
CNBC's Kelly Evans reports on all the market moving activity in European markets, including an emergency meeting held today by G7 Finance chiefs on worries about a possible run on Spanish banks.
The Dow retreat is part of a new downtrend with initial downside targets near 11,300.
Investors are pouring money back into high yield, or junk bonds, as they prepare for a long and winding low interest rate environment, reports CNBC's Kayla Tausche. Ron Kruszewski, Stifel Nicolaus CEO and Jim Iuorio, TJM Institutional Services, discuss April factory orders, the European crisis and the state of the U.S. recession.
Mad Money host Jim Cramer and Harvey Berger, Ariad Pharmaceuticals chairman/CEO, discuss the state of the health care sector and Ariad's recent research for Sarcoma, Leukemia and other cancers.
Mad Money host Jim Cramer discusses why the Fed should not be buying and why the Treasury Department should be selling.
Daniel Junius, ImmunoGen chairman/CEO, discusses the latest developments in therapeutics for the treatment of cancer.
Mad Money host Jim Cramer explains why the market is worse off than where it stood in August and October of 2011, but not even close to a 2009 scenario.
The Fast Money traders discuss how an increase in new vehicle sales year-over-year could positively impact AutoNation.
The Fast Money traders discuss the trade on Priceline amid its decline; and even portfolio pros are feeling the heat from the volatility in the markets, with Whitney Tilson, T2 Partners founder. Scott Nations, NationsShares, also weighs in on the trade in financials.
Shawn Reynolds, Van Eck Global Hard Assets Fund, explains why he is betting on oil E&P stocks.
The Fast Money traders and Dennis Gartman, The Gartman Letter, discuss the ongoing weakness in the markets and whether further QE from the Fed could help.
Anthony Coles, Onyx Pharmaceuticals president/CEO, discusses the status of his company's latest drugs.